World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Abbott Labs Spices Up Its Drug Portfolio
Keywords:
Tags: Pharmaceutical, India,
Analysts say Abbott has paid a steep price for India's Piramal Health Care. Abbott is buying the Indian drug company for $3.72 billion, which is 48% above Piramal's market cap. Going by Piramal sales of $500 million a year , this is 7 times expected sales. Daiichi Sankyo paid 4 times sales for Ranbaxy in 2008. Analysts say this will give Abbott a 7% market share in India's branded generics market. Yet this market is highly fragmented with the top 20 makers having 60% of the market and many small companies.
Abbott Labs acquisitions.
10/19/2006
Grouped Articles
Abbott Buys Drug Maker in India for $3.7 Billion
New York Times 05/21/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Labs performance
10/19/2006
Grouped Articles
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Labs Licenses Molecules from Reata
Wall Street Journal 12/12/2011
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Is Buoyed By Arthritis Drug, Guidant's Stents - WSJ.com
Wall Street Journal 10/19/2006
Abbott in emerging markets.
02/26/2009
Grouped Articles
Emerging Markets Are on Their Own
Wall Street Journal 06/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Plant Is New Move To Tap Asia
Wall Street Journal 02/26/2009
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs international operations.
05/22/2010
Grouped Articles
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
The Four Ps of Global Business Expansion
Wall Street Journal 11/12/2010
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott Labs India
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Buys Drug Maker in India for $3.7 Billion
New York Times 05/21/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs strategies
10/19/2006
Grouped Articles
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Labs Licenses Molecules from Reata
Wall Street Journal 12/12/2011
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
Abbott acquisitions.
09/25/2009
Grouped Articles
Abbott Buys Drug Maker in India for $3.7 Billion
New York Times 05/21/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Joins Bidding for Solvay Drug Unit
Wall Street Journal 09/25/2009
Abbott in $6.6 Billion Deal for Drug Unit
New York Times 09/28/2009
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Looks to Consumer for Growth
Wall Street Journal 05/03/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us